Menu
Back to User profile » Dr Santiago Grau
Papers published by Dr Santiago Grau:
Ceftaroline Fosamil for the Empiric Treatment of Hospitalized Adults with cSSTI: An Economic Analysis from the Perspective of the Spanish National Health System
Torres A, Soriano A, Rivolo S, Remak E, Peral C, Kantecki M, Ansari W, Charbonneau C, Hammond J, Grau S, Wilcox M
ClinicoEconomics and Outcomes Research 2022, 14:149-161
Published Date: 18 March 2022
Extremely high levels of vancomycin can cause severe renal toxicity
Barceló-Vidal J, Rodríguez-García E, Grau S
Infection and Drug Resistance 2018, 11:1027-1030
Published Date: 30 July 2018
Posaconazole achieves prompt recovery of voriconazole-induced liver injury in a case of invasive aspergillosis
Martínez-Casanova J, Carballo N, Luque S, Sorli L, Grau S
Infection and Drug Resistance 2018, 11:317-321
Published Date: 5 March 2018
Cost-effectiveness analysis of combination antifungal therapy with voriconazole and anidulafungin versus voriconazole monotherapy for primary treatment of invasive aspergillosis in Spain
Grau S, Azanza JR, Ruiz I, Vallejo C, Mensa J, Maertens J, Heinz WJ, Barrueta JA, Peral C, Mesa FJ, Barrado M, Charbonneau C, Rubio-Rodríguez D, Rubio-Terrés C
ClinicoEconomics and Outcomes Research 2017, 9:39-47
Published Date: 30 December 2016
Costs of adverse events associated with erlotinib or afatinib in first-line treatment of advanced EGFR-positive non-small cell lung cancer
Isla D, De Castro J, Juan O, Grau S, Orofino J, Gordo R, Rubio-Terrés C, Rubio-Rodríguez D
ClinicoEconomics and Outcomes Research 2017, 9:31-38
Published Date: 30 December 2016
Cost-effectiveness of three echinocandins and fluconazole in the treatment of candidemia and/or invasive candidiasis in nonneutropenic adult patients
Grau S, Pozo JC, Romá E, Salavert M, Barrueta JA, Peral C, Rodriguez I, Rubio-Rodríguez D, Rubio-Terrés C
ClinicoEconomics and Outcomes Research 2015, 7:527-535
Published Date: 13 October 2015
Antibiotic expected effectiveness and cost under real life microbiology: evaluation of ertapenem and ceftriaxone in the treatment of community-acquired pneumonia for elderly patients in Spain
Grau S, Lozano V, Valladares A, Cavanillas R, Xie Y, Nocea G
ClinicoEconomics and Outcomes Research 2014, 6:83-92
Published Date: 13 February 2014
Potential role of tedizolid phosphate in the treatment of acute bacterial skin infections
Urbina O, Ferrández O, Espona M, Salas E, Ferrández I, Grau S
Drug Design, Development and Therapy 2013, 7:243-265
Published Date: 3 April 2013